FDA WARNING_LETTER - Electronic Puffs

The FDA Center for Tobacco Products issued a Warning Letter to Electronicpuff.co.uk after reviewing their website and determining that e-liquid products, specifically Vype Infused Vanilla e-liquid, are offered for sale or distribution to U.S. customers. These e-liquids are classified as tobacco products under section 201(rr) of the FD&C Act.

The primary violation identified is the sale of Vype Infused Vanilla e-liquid to a person younger than 18 years of age, which constitutes misbranding under section 903(a)(7)(B) of the FD&C Act. This violates 21 C.F.R. § 1140.14(b), which prohibits retailers from selling covered tobacco products, including e-liquids, to minors. The product is deemed a "covered tobacco product" under 21 C.F.R. § 1140.3.

Electronicpuff.co.uk is required to immediately correct this violation and any similar ones, ensuring all tobacco products and related advertising comply with the FD&C Act. Failure to comply may result in further FDA actions, including civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, or injunction. Adulterated and misbranded products imported into the U.S. are subject to detention. A written response detailing corrective actions, including discontinuation dates and a compliance plan,